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bilateral innominate vein occlusion from radiation therapy
for lung carcinoma and central line–induced thrombosis.
A modified saphenojugular bypass grafting procedure was
performed and successfully relieved the SVC syndrome.
CASE REPORT
A 55-year-old woman had a 1-month duration of recurrent
head, neck, and arm swelling with facial flushing and a feeling of
head fullness, disabling headaches, blurry vision, and severe
orthopnea. On physical examination, she had marked swelling of
both upper extremities, the face, and the neck and significant
palpebral and scleral edema with facial cyanosis. Large chest wall
venous collaterals were present bilaterally, extending to the shoul-
ders. The presternal area was remarkable for severe skin erythema
and cardboard-like induration. Her medical history was signifi-
cant for the diagnosis 6 months earlier of SVC syndrome caused
by a right upper-lobe small-cell lung carcinoma. After radiation
therapy and chemotherapy, her SVC syndrome had resolved.
Recurrent swelling limited only to the right arm subsequently
developed, and this was only moderately disabling. At that time,
no evidence of tumor recurrence was shown by means of a chest
computerized tomography scan, and right arm swelling was
caused by right innominate vein occlusion. A month before her
referral to our institution, her SVC syndrome recurred with dis-
abling symptoms. Two weeks before her examination at our insti-
tution, a venogram was performed, and extensive thrombosis of
the left innominate vein extending into the left internal jugular,
subclavian, and axillobrachial veins was shown. This extensive
thrombosis was induced by a permanent central venous catheter
(Port-A-Cath) that was placed for chemotherapy. The Port-A-
Cath was removed, and she had two failed attempts at thrombol-
ysis with urokinase, which only partially recanalized the left
axillobrachial vein. After this failure, she was referred to our insti-
tution. A bilateral upper-extremity venogram was performed, and
bilateral innominate vein occlusion with extension into the left
internal jugular and subclavian veins was shown (Fig 1). A trans-
femoral venous approach was then used as a means of recanalizing
Superior vena cava (SVC) syndrome is a disabling and
potentially life-threatening complication seen with increas-
ing prevalence. The causes of SVC obstruction have been
classically divided between malignant and benign ones.
Mediastinal malignancy, either primary or metastatic,
remains the most common etiology of SVC syndrome.1
Mediastinal fibrosis is the most common benign cause;
however, iatrogenic etiologies from placement of central
lines, pacemaker wires, or permanent indwelling catheters
are increasingly more frequent and responsible for an
increasing prevalence of SVC syndrome. Endovascular
modalities and direct surgical reconstruction are the two
main revascularization options for SVC obstruction.
Endovascular treatment with angioplasty or stenting is
usually offered as a first line of treatment for malignant
SVC syndrome.2 SVC syndrome from benign causes is
best managed in patients who are at good risk with direct
transthoracic SVC reconstruction. Direct SVC reconstruc-
tion has been performed with spiral saphenous vein graft,
superficial femoral vein, or externally supported expanded
polytetrafluoroethylene (ePTFE) graft.3-5 Surgical recon-
struction by means of peripheral venous bypass grafting
has remained a rarely performed operation. We report on
a patient with severely symptomatic SVC syndrome from
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Superior vena cava (SVC) syndrome is a disabling and potentially life-threatening complication. SVC revascularization
can be achieved by means of endovascular or direct surgical reconstructions. In the patient on whom we report, these
two options were not possible, and a peripheral venous bypass grafting procedure was done with a technical innova-
tion. Right upper-extremity swelling developed in a 55-year-old woman after radiation therapy for lung carcinoma. A
left subclavian vein Port-A-Cath induced extensive thrombosis of the left innominate, axillosubclavian, and jugular
veins. She was referred to our institution with very symptomatic SVC syndrome after two failed endovascular inter-
ventions. The occlusion of both innominate veins and chronic thrombus extending into the left axillosubclavian and
internal jugular veins was confirmed by means of a venogram. A third endovascular attempt failed. The presternal skin
had severe radiation-induced damage precluding direct SVC reconstruction. A bypass grafting procedure from the right
internal jugular to the femoral vein was performed with spliced bilateral greater saphenous veins tunneled inside an
externally supported expanded polytetrafluoroethylene graft. Postoperatively, the patient had no symptoms, and graft
patency was confirmed by means of duplex ultrasound scanning. A saphenojugular bypass grafting procedure can offer
prompt and durable relief of SVC syndrome when endovascular or direct surgical reconstructions are not possible. This
rarely used peripheral venous bypass grafting procedure was modified by tunneling the vein graft inside an externally
supported polytetrafluoroethylene graft to prevent kinking or compression. (J Vasc Surg 2001;34:360-3.)
the innominate veins, but it was unsuccessful despite the use of
thrombolysis and multiple attempts at guidewire traverse through
the occluded innominate veins from above and below (Fig 2). A
thrombotic occlusion of the left internal jugular vein was con-
firmed by means of a duplex ultrasound scan of the neck, but the
right internal jugular vein was patent through cervicothoracic col-
laterals.
Three attempts at endovascular management of this patient’s
severely symptomatic SVC syndrome had already failed. The
extensive radiation-induced skin damage in the presternal area
precluded a direct transthoracic approach. The use of a peripheral
venous bypass grafting procedure appeared to be the only remain-
ing option. Preoperative duplex ultrasound scanning mapping
was performed, and both greater saphenous veins were identified
as being adequate conduits from the saphenofemoral junction to
the level of the knees. Our surgical approach included a right neck
incision to expose the internal jugular vein and bilateral thigh
incisions to harvest the greater saphenous veins (Fig 3). The right
saphenous vein was not disconnected from the saphenofemoral
junction, but simply turned toward the neck after ligating all trib-
utaries to prevent kinking (Fig 4, A). The left greater saphenous
vein was reversed and anastomosed to the right internal jugular
vein, which was found to be small and thickened but patent (Fig
4, B). Both vein grafts were tunneled laterally to avoid the area of
radiation-damaged skin and tunneled inside an externally sup-
ported 8-mm ePTFE graft that was divided at the level of the lat-
eral chest wall incision to anastomose both vein grafts (Fig 5).
The vein grafts were then spliced together at mid-chest at the site
of a small counter incision. Venous pressures were measured intra-
operatively. Before the bypass grafting procedure, the right inter-
nal jugular venous pressure was 29 mm Hg, and the right femoral
venous pressure was 12 mm Hg. After the bypass grafting proce-
dure, the jugular venous pressure dropped to 15 mm Hg. The
intraoperative graft flow was 70 mL/min by means of electro-
magnetic probe measurement (Carolina Electronics, King, NC).
The patient’s postoperative course was uneventful, with
prompt relief of facial flushing, blurry vision, headaches, and
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orthopnea. She also had a progressive decrease in head, neck, and
arm edema. Postoperatively, before the patient was discharged,
graft patency was confirmed by means of a duplex ultrasound scan
and a magnetic resonance angiogram, and graft flow was mea-
sured at 220 mL/min by means of the cine phase contrast
method. She was discharged from the hospital on postoperative
day 9, having been prescribed a long-term regimen of oral anti-
coagulation with warfarin (Coumadin). She returned 2 months
later with no symptoms and with a patent graft. At 11 months’
follow-up, the SVC syndrome had not recurred, and graft patency
was reconfirmed by means of an ultrasound scan; however, the
patient died of metastatic lung carcinoma.
DISCUSSION
Direct reconstruction of the SVC is our first therapeu-
tic option in young patients with symptomatic nonmalig-
nant SVC syndrome who are at low operative risk.
Peripheral venous bypass grafting for superior vena cava
syndrome
No. of Anasto- SVCS
Author patients mosis Graft Survival outcome
Schramel 1 EJV Patent 42 d Resolved
Taylor 1 EJV Patent 5 mo Resolved
Vincze 7 EJV All patent 2-14 mo All resolved
Gutowicz 1 AxV Patent 8 mo Resolved
Ham 1 EJV Patent 15 y Resolved
IJV Thrombosed 1 y
Graham 3 IJV (2) All patent 1.5-13 mo All resolved
EJV (1)
Al-Salman 1 EJV Patent 18 mo Resolved
SVCS, Superior vena cava syndrome; EJV, external jugular vein; AxV, axil-
lary vein; IJV, internal jugular vein.
Fig 1. Bilateral upper-extremity venogram (A and B) showing bilateral innominate vein occlusion with extension of thrombotic occlu-
sion into left internal jugular and axillosubclavian veins (B).
A B
Acceptable graft patency rates can be obtained with effec-
tive relief of symptoms.3-5 For symptomatic malignant
SVC syndrome, endovascular techniques by means of per-
cutaneous balloon angioplasty with or without stenting
are now considered to be the first line of treatment.2
These minimally invasive approaches have been successful
in relieving symptoms at short-term and midterm follow-
up. Recurrence of symptoms from restenosis can usually
be dealt with by means of repeated endovascular proce-
dures.4 Infrequently, endovascular techniques fail, or
direct reconstruction of the SVC is contraindicated. This
was the case in our patient, in whom three attempts at
endovascular modalities had failed and who had severe
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radiation-induced skin changes in the presternal area that
precluded median sternotomy and direct revascularization
of the SVC. In these situations, peripheral venous bypass
grafting can provide an adequate way of decompressing
the brachiocephalic venous hypertension from malignant
or benign SVC syndrome. Earlier experience with periph-
Fig 3. Schematic drawing showing a right neck incision to expose
internal jugular vein, with bilateral thigh incisions to harvest
greater saphenous veins and small lateral incision at mid-chest for
tunneling vein grafts.
Fig 2. Superior vena cavogram from a transfemoral approach
confirmed occlusion of entire right innominate vein and opacified
only proximal left innominate vein. Fig 4. A, Ipsilateral greater saphenous vein after ligating and
dividing its tributaries was turned cephalad and tunneled through
a polytetrafluoroethylene (PTFE) graft placed subcutaneously.
SFJ, Saphenofemoral junction; CFV, common femoral vein. 
B, Contralateral greater saphenous vein (GSV) was anastomosed
end to side to right internal jugular vein (IJV) and then tunneled
through a polytetrafluoroethylene (PTFE) graft.
A
B
Fig 5. Schematic drawing showing both saphenous veins tun-
neled through PTFE grafts and anastomosed end to end in a spat-
ulated manner at the level of the lateral chest wall counter
incision.
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eral venous bypass grafting to relieve SVC syndrome has
remained very small. All previously reported cases have
been performed in patients with symptomatic SVC syn-
drome (Table).6-12 Schramel and Olinde6 performed the
first saphenojugular bypass grafting procedure with the
external jugular vein. Their patient had a slow resolution
of the SVC syndrome, but died 42 days later. The largest
experience with the use of saphenojugular bypass grafting
for malignant SVC syndrome was reported by Vincze et
al.8 The saphenous vein was anastomosed end-to-side to
the external jugular vein in all seven of their cases, and in
two of these cases, spliced bilateral greater saphenous vein
had to be used. All grafts were patent at follow-up, the
period of which ranged from 2 to 14 months, and all seven
patients had resolution of their SVC syndrome.8 Gutowicz
et al9 reported a modification of this peripheral venous
bypass grafting procedure involving anastomosing the
saphenous vein to the axillary vein. This was effective in
relieving the SVC syndrome, and the graft was patent at 8
months. Ham et al10 described, in 1985, a patient treated
by means of a saphenojugular bypass grafting procedure
with the external jugular vein with only partial resolution
of the SVC syndrome. They returned 6 weeks later to per-
form a contralateral saphenojugular bypass grafting proce-
dure and used, for the first time, the internal jugular vein.
This led to complete resolution of the SVC syndrome.
Graham et al11 were the first to primarily perform this sub-
cutaneous saphenojugular bypass grafting procedure with
the internal jugular vein.
Reviewing the literature, we found 15 patients who
underwent a peripheral venous bypass grafting procedure
for relief of SVC syndrome (Table). In 13 patients, the
SVC syndrome was caused by malignant obstruction; in
the remaining two patients, it was caused by tuberculosis.
The external jugular vein was used in 12 patients, the
internal jugular vein was used in 3 patients, and the axil-
lary vein was used in 1 patient. The SVC syndrome
resolved in all patients, and all grafts except one remained
patent for a mean follow-up period of 18 months (range,
42 days to 15 years).
We modified this saphenojugular bypass grafting pro-
cedure by tunneling an externally supported ePTFE graft
subcutaneously to act as a protective sleeve for the saphe-
nous veins to avoid kinking or compression. We felt that
the PTFE sleeve was an appropriate adjunct in this partic-
ular patient, because significant postradiation soft tissue
induration was compounded by severe obesity, thus
increasing the risk of graft kinking. This modification had
not previously been used for this subcutaneous peripheral
venous reconstruction. However, it had been previously
described in a patient with a recurrent SVC syndrome
managed by means of reconstruction of the SVC with a
femoral vein protected by an externally supported ePTFE
graft.13 We believe that the internal jugular vein should be
the preferred vessel to anastomose the saphenous vein to
provide direct decompression of the brachiocephalic
venous hypertension. However, other authors have suc-
cessfully used the external jugular vein with good resolu-
tion of SVC syndrome, although in two cases, resolution
was partial or slow. This type of venous bypass grafting
requires a meticulous technique and surgical expertise in
venous reconstruction.
A saphenojugular bypass grafting procedure can offer
prompt, effective, and durable relief of SVC syndrome
from malignant obstruction when endovascular or direct
surgical reconstructions have failed or are not possible.
This rarely performed peripheral venous bypass grafting
procedure should be part of the armamentarium of sur-
geons managing complex or recurrent malignant SVC
syndrome.
We thank Rhonda Hartman for her assistance in
manuscript preparation and Michael King for his assistance
in medical illustration.
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